Found: 59
Select item for more details and to access through your institution.
Long-term outcome of repeated septal reduction therapy after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: insight from the Euro-ASA registry.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The impact of stroke and bleeding on mortality and quality of life during the first year after TAVI: A POPular TAVI subanalysis.
- Published in:
- Catheterization & Cardiovascular Interventions, 2024, v. 104, n. 5, p. 1107, doi. 10.1002/ccd.31218
- By:
- Publication type:
- Article
Validation of the HCM Risk-SCD model in patients with hypertrophic cardiomyopathy following alcohol septal ablation.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Ticagrelor Versus Clopidogrel in Older Patients with NSTE-ACS Using Oral Anticoagulation: A Sub-Analysis of the POPular Age Trial.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 10, p. 3249, doi. 10.3390/jcm9103249
- By:
- Publication type:
- Article
Rationale and Design of the Future Optimal Research and Care Evaluation in Patients with Acute Coronary Syndrome (FORCE-ACS) Registry: Towards "Personalized Medicine" in Daily Clinical Practice.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 10, p. 3173, doi. 10.3390/jcm9103173
- By:
- Publication type:
- Article
Prehospital tirofiban increases the rate of disrupted myocardial infarction in patients with ST-segment elevation myocardial infarction: insights from the On-TIME 2 trial.
- Published in:
- European Heart Journal: Acute Cardiovascular Care, 2024, v. 13, n. 8, p. 595, doi. 10.1093/ehjacc/zuae074
- By:
- Publication type:
- Article
Reply to: "Paraoxonase-1 and clopidogrel efficacy".
- Published in:
- 2011
- By:
- Publication type:
- Letter
Corrigendum: Paraoxonase-1 is a major determinant of clopidogrel efficacy.
- Published in:
- 2011
- By:
- Publication type:
- Correction Notice
Paraoxonase-1 is a major determinant of clopidogrel efficacy.
- Published in:
- Nature Medicine, 2011, v. 17, n. 1, p. 110, doi. 10.1038/nm.2281
- By:
- Publication type:
- Article
Bedside testing of CYP2C19 gene for treatment of patients with PCI with antiplatelet therapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Dabigatran Dual Therapy vs Warfarin Triple Therapy Post-Percutaneous Coronary Intervention in Patients with Atrial Fibrillation With/Without a Proton Pump Inhibitor: A Pre-Specified Analysis of the RE-DUAL PCI Trial.
- Published in:
- Drugs, 2020, v. 80, n. 10, p. 995, doi. 10.1007/s40265-020-01323-x
- By:
- Publication type:
- Article
The puzzle of antiplatelet therapy in ACS: ticagrelor monotherapy is another missing piece.
- Published in:
- European Heart Journal, 2024, v. 45, n. 33, p. 3057, doi. 10.1093/eurheartj/ehae440
- By:
- Publication type:
- Article
The year in cardiovascular medicine 2023: the top 10 papers in thrombosis and antithrombotic treatment.
- Published in:
- European Heart Journal, 2024, v. 45, n. 19, p. 1727, doi. 10.1093/eurheartj/ehae123
- By:
- Publication type:
- Article
Antithrombotic therapy in patients undergoing trans catheter aortic valve implantation.
- Published in:
- European Heart Journal, 2021, v. 42, n. 33, p. 3205, doi. 10.1093/eurheartj/ehab380
- By:
- Publication type:
- Article
Patient-tailored antithrombotic therapy following percutaneous coronary intervention.
- Published in:
- European Heart Journal, 2021, v. 42, n. 10, p. 1038, doi. 10.1093/eurheartj/ehaa1097
- By:
- Publication type:
- Article
Short- and long-term outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy in patients with mild left ventricular hypertrophy: a propensity score matching analysis.
- Published in:
- European Heart Journal, 2019, v. 40, n. 21, p. 1681, doi. 10.1093/eurheartj/ehz110
- By:
- Publication type:
- Article
Incidence and Causes for Early Ticagrelor Discontinuation: A "Real-World" Dutch Registry Experience.
- Published in:
- Cardiology, 2017, v. 138, n. 3, p. 164, doi. 10.1159/000475705
- By:
- Publication type:
- Article
CT-Derived Patient-Specific Computer Simulation of the Novel Self-Expanding Evolut FX Implantation: A Case Series.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 20, p. 6212, doi. 10.3390/jcm13206212
- By:
- Publication type:
- Article
Differential Impact of Cytochrome 2C19 Allelic Variants on Three Different Platelet Function Tests in Clopidogrel-Treated Patients.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 17, p. 3992, doi. 10.3390/jcm10173992
- By:
- Publication type:
- Article
What Can We Learn from the Past by Means of Very Long-Term Follow-Up after Aortic Valve Replacement?
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 17, p. 3925, doi. 10.3390/jcm10173925
- By:
- Publication type:
- Article
CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case–control study.
- Published in:
- European Heart Journal, 2010, v. 31, n. 24, p. 3046, doi. 10.1093/eurheartj/ehq321
- By:
- Publication type:
- Article
A single dose of erythropoietin in ST-elevation myocardial infarction.
- Published in:
- European Heart Journal, 2010, v. 31, n. 21, p. 2593
- By:
- Publication type:
- Article
Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials.
- Published in:
- European Heart Journal, 2010, v. 31, n. 1, p. 35, doi. 10.1093/eurheartj/ehp376
- By:
- Publication type:
- Article
One year outcomes with abciximab vs. placebo during percutaneous coronary intervention after pre-treatment with clopidogrel<sup>†</sup>.
- Published in:
- European Heart Journal, 2005, v. 26, n. 14, p. 1379, doi. 10.1093/eurheartj/ehi174
- By:
- Publication type:
- Article
Is there a place for heart-type fatty acid binding protein in the era of high-sensitive cardiac troponin T for the diagnosis of acute myocardial infarction? A systematic review.
- Published in:
- Emergency Care Journal, 2019, v. 15, n. 2, p. 51, doi. 10.4081/ecj.2019.8049
- By:
- Publication type:
- Article
2023 European Society of Cardiology guidelines for the management of acute coronary syndromes: Statement of endorsement by the NVVC.
- Published in:
- Netherlands Heart Journal, 2024, v. 32, n. 10, p. 338, doi. 10.1007/s12471-024-01896-2
- By:
- Publication type:
- Article
Reply to 'Revisiting postsurgical aortic pseudoaneurysm mortality and treatment options'.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis.
- Published in:
- Netherlands Heart Journal, 2023, v. 31, n. 12, p. 489, doi. 10.1007/s12471-023-01824-w
- By:
- Publication type:
- Article
Transcatheter closure of postsurgical aortic pseudoaneurysms guided by three-dimensional image reconstruction: a single-centre experience.
- Published in:
- Netherlands Heart Journal, 2023, v. 31, n. 10, p. 383, doi. 10.1007/s12471-023-01784-1
- By:
- Publication type:
- Article
Comparison of Platelet Function Tests in Predicting Clinical Outcome in Patients Undergoing Coronary Stent Implantation.
- Published in:
- JAMA: Journal of the American Medical Association, 2010, v. 303, n. 8, p. 754, doi. 10.1001/jama.2010.181
- By:
- Publication type:
- Article
Abciximab in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention After Clopidogrel Pretreatment: The ISAR-REACT 2 Randomized Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2006, v. 295, n. 13, p. 1531, doi. 10.1001/jama.295.13.joc60034
- By:
- Publication type:
- Article
A clinical risk score to identify patients at high risk of very late stent thrombosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
High risk of stent thrombosis in the first 6 months after coronary stenting: Do not discontinue clopidogrel early after ACS.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Percutaneous Atrial Shunt Closure Using the Novel Occlutech Figulla Device: 6-Month Efficacy and Safety.
- Published in:
- Journal of Interventional Cardiology, 2011, v. 24, n. 3, p. 264, doi. 10.1111/j.1540-8183.2010.00619.x
- By:
- Publication type:
- Article
Double-Trouble: Three Cases with Simultaneous Stent Thrombosis in Different Coronary Arteries.
- Published in:
- Journal of Interventional Cardiology, 2007, v. 20, n. 2, p. 132, doi. 10.1111/j.1540-8183.2007.00240.x
- By:
- Publication type:
- Article
Cutting Balloon for In-Stent Restenosis:.
- Published in:
- Journal of Interventional Cardiology, 2004, v. 17, n. 4, p. 197, doi. 10.1111/j.1540-8183.2004.00378.x
- By:
- Publication type:
- Article
Stenting for Restenotic Lesions with the BARD XT Stent.
- Published in:
- Journal of Interventional Cardiology, 2003, v. 16, n. 3, p. 227, doi. 10.1034/j.1600-0854.2003.8050.x
- By:
- Publication type:
- Article
Tailored P2Y<sub>12</sub> inhibitor treatment in patients undergoing non-urgent PCI—the POPular Risk Score study.
- Published in:
- European Journal of Clinical Pharmacology, 2019, v. 75, n. 9, p. 1201, doi. 10.1007/s00228-019-02696-z
- By:
- Publication type:
- Article
Effect of aortic cross-clamp time on late survival after isolated aortic valve replacement.
- Published in:
- Interactive Cardiovascular & Thoracic Surgery, 2021, v. 32, n. 2, p. 222, doi. 10.1093/icvts/ivaa244
- By:
- Publication type:
- Article
CYP2C9 Polymorphisms and the Risk of Cardiovascular Events in Patients Treated with Clopidogrel: Combined Data from the POPular Genetics and POPular AGE Trials.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 2, p. 165, doi. 10.1007/s40256-022-00565-2
- By:
- Publication type:
- Article
Critical Analysis of Thrombocytopenia Associated With Glycoprotein IIb/IIIa Inhibitors and Potential Role of Zalunfiban, a Novel Small Molecule Glycoprotein Inhibitor, in Understanding the Mechanism(s).
- Published in:
- Journal of the American Heart Association, 2023, v. 12, n. 24, p. 1, doi. 10.1161/JAHA.123.031855
- By:
- Publication type:
- Article
Factor V Leiden and the Risk of Bleeding in Patients With Acute Coronary Syndromes Treated With Antiplatelet Therapy: Pooled Analysis of 3 Randomized Clinical Trials.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Factor V Leiden Does Not Modify the Phenotype of Acute Coronary Syndrome or the Extent of Myocardial Necrosis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Outcome of Alcohol Septal Ablation in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy: A Long-Term Follow-Up Study Based on the Euro-Alcohol Septal Ablation Registry.
- Published in:
- Journal of the American Heart Association, 2017, v. 6, n. 5, p. 1, doi. 10.1161/JAHA.117.005735
- By:
- Publication type:
- Article
Diagnostic performance and clinical implications for enhancing a hybrid quantitative flow ratio–FFR revascularization decision-making strategy.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-85933-9
- By:
- Publication type:
- Article
The Clinical Implementation of CYP2C19 Genotyping in Patients with an Acute Coronary Syndrome: Insights From the FORCE-ACS Registry.
- Published in:
- Journal of Cardiovascular Pharmacology & Therapeutics, 2023, v. 28, p. 1, doi. 10.1177/10742484231210704
- By:
- Publication type:
- Article
High-sensitivity cardiac troponin T predicts mortality after hospitalization for community-acquired pneumonia.
- Published in:
- Respirology, 2017, v. 22, n. 5, p. 1000, doi. 10.1111/resp.12996
- By:
- Publication type:
- Article
Comparison of the effects of the GPIIb-IIIa antagonist Zalunfiban and the P2Y12 antagonist Selatogrel on Platelet Aggregation.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2023, v. 56, n. 4, p. 499, doi. 10.1007/s11239-023-02867-x
- By:
- Publication type:
- Article
Efficacy and safety of glycoprotein IIb/IIIa inhibitors in addition to P2Y<sub>12</sub> inhibitors in ST‐segment elevation myocardial infarction: A subanalysis of the POPular Genetics trial.
- Published in:
- Catheterization & Cardiovascular Interventions, 2022, v. 99, n. 3, p. 676, doi. 10.1002/ccd.29861
- By:
- Publication type:
- Article
Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO‐3 randomized trial.
- Published in:
- Catheterization & Cardiovascular Interventions, 2020, v. 96, n. 3, p. E377, doi. 10.1002/ccd.28642
- By:
- Publication type:
- Article